Targeted Oncology1h
Wildfires’ Impact on Patients With Cancer: Lessons in Crisis Response
The California wildfires severely affected patients with cancer, requiring evacuation protocols, community support, and ...
Targeted Oncology3h
FDA Grants 510(k) Clearance to Ibex Prostate Detect AI for Prostate Cancer
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...
Targeted Oncology3h
FDA Fast Tracks Amezalpat for HCC Treatment
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.
Targeted Oncology5h
Seeking Optimal Combinations and Treatment Sequencing in Cervical Cancer
Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...
Targeted Oncology21h
Evaluating Agents to Manage Low-Risk Myelodysplastic Syndrome
Saeed Sadeghi, MD, discusses treatment options in low-risk myelodysplastic syndrome at a Case-Based Roundtable event.